DIS vs PFE: Which Is the Better Buy?
Side-by-side comparison of The Walt Disney Company and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
The Walt Disney Company · Communication Services
$101.31
+66.6% upside to fair value
Grade B
VS
Pfizer Inc. · Healthcare
$26.33
+35.4% upside to fair value
Grade B
QuantHub Verdict
DIS has more upside to fair value
(+66.6%).
DIS trades at a lower forward P/E
(14.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DIS |
PFE |
| Current Price |
$101.31 |
$26.33 |
| Fair Value Estimate |
$168.80 |
$35.65 |
| Upside to Fair Value |
+66.6%
|
+35.4%
|
| Market Cap |
$179.5B |
$149.8B |
| Forward P/E |
14.8x
|
19.3x
|
| EV / EBITDA |
11.4x
|
12.9x
|
| Price / Sales |
1.9x
|
2.4x
|
| Price / FCF |
25.4x
|
16.5x
|
| Revenue Growth YoY |
+5.2%
|
-1.2%
|
| Gross Margin |
37.3%
|
70.3%
|
| Operating Margin |
14.2%
|
24.7%
|
| Return on Equity |
11.3%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.93%
|
6.06%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
The Walt Disney Company operates as a diversified entertainment giant with strong competitive advantages from its vast intellectual property portfolio, global theme parks, and growing direct-to-consumer streaming platforms. The company demonstrates medium business quality with a durable moat supported by iconic brands and infrastructure, but faces execution risks in streaming profitability and pa…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
DIS |
PFE |
| Zone Low |
$126.60 |
$26.74 |
| Zone High |
$143.48 |
$30.30 |
| In Buy Zone? |
Yes
|
Yes
|